|
Volumn 110, Issue 5, 2015, Pages 770-771
|
Combination therapy with sorafenib and radiofrequency ablation for hepatocellular carcinoma: A glimmer of light after the storm trial¿
|
Author keywords
[No Author keywords available]
|
Indexed keywords
SORAFENIB;
ANTINEOPLASTIC AGENT;
CARBANILAMIDE DERIVATIVE;
NICOTINAMIDE;
CANCER ADJUVANT THERAPY;
CANCER PATIENT;
CANCER SURGERY;
CANCER SURVIVAL;
HUMAN;
LETTER;
LIVER CELL CARCINOMA;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
RADIOFREQUENCY ABLATION;
RECURRENCE FREE SURVIVAL;
RETROSPECTIVE STUDY;
ANALOGS AND DERIVATIVES;
CARCINOMA, HEPATOCELLULAR;
CATHETER ABLATION;
FEMALE;
LIVER NEOPLASMS;
MALE;
PROCEDURES;
ANTINEOPLASTIC AGENTS;
CARCINOMA, HEPATOCELLULAR;
CATHETER ABLATION;
FEMALE;
HUMANS;
LIVER NEOPLASMS;
MALE;
NIACINAMIDE;
PHENYLUREA COMPOUNDS;
|
EID: 84928887852
PISSN: 00029270
EISSN: 15720241
Source Type: Journal
DOI: 10.1038/ajg.2015.80 Document Type: Letter |
Times cited : (12)
|
References (5)
|